Home ARH missense polymorphisms and plasma cholesterol levels
Article
Licensed
Unlicensed Requires Authentication

ARH missense polymorphisms and plasma cholesterol levels

  • Jaroslav A. Hubacek and Tommy Hyatt
Published/Copyright: June 1, 2005

Abstract

Mutations in a putative low-density lipoprotein (LDL) receptor adaptor protein called ARH have been recently described in patients with autosomal recessive hypercholesterolemia (ARH). ARH plays a tissue-specific role in determination of LDL receptor function. In the ARH gene three mismatched polymorphisms have been detected: Pro202Ser, Pro202His and Arg238Trp. These are of putative interest in plasma cholesterol level determination. To evaluate the effect of polymorphisms on plasma cholesterol levels, all polymorphisms were analyzed by PCR and restriction enzyme analysis by MnlI, HpyCH4IV and SacII in 100 Caucasian males with high (>90%, 6.29 ± 0.89 mmol/l), and 100 males with low (<10%, 3.60 ± 0.57 mmol/l), total plasma cholesterol levels. No significant differences were observed in frequencies of ARH genotypes or alleles between these two extreme groups. These results suggest that ARH polymorphisms are unlikely to be important genetic determinants of plasma cholesterol levels.


Corresponding author: J. A. Hubacek, IKEM, CEM, Laboratory of Molecular Genetics, Videnska 1958/9, 140 21 Prague, Czech Republic. Phone: +420/261 363 367, Fax: +420/261 362 236, E-mail:

References

1 Garcia CK, Wilund K, Arca M, Zuliani G, Felini R, Maioli M, et al. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 2001; 292:1394–8.10.1126/science.1060458Search in Google Scholar

2 Arca M, Zuliani G, Wilund K, Campagna F, Felini R, Bertolini S, et al. Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis. Lancet 2002; 359:841–7.10.1016/S0140-6736(02)07955-2Search in Google Scholar

3 Al Kateb H, Bähring S, Hoffmann K, Strauch K, Busjahn A, Nűrnberg G, et al. Mutation in the ARH gene and a chromosome 13q locus influence cholesterol levels in a new form of digenic-recessive familial hypercholesterolemia. Circ Res 2002; 90:951–8.10.1161/01.RES.0000018002.43041.08Search in Google Scholar

4 Fellin R, Zuliani G, Arca M, Pintus P, Pacifico A, Montali A, et al. Clinical and biochemical characterisation of patients with autosomal recessive hypercholesterolemia (ARH). Nutr Metab Cardiovasc Dis 2003; 13:278–86.10.1016/S0939-4753(03)80032-7Search in Google Scholar

Received: 2003-11-26
Accepted: 2004-8-20
Published Online: 2005-6-1
Published in Print: 2004-9-1

© Walter de Gruyter

Articles in the same Issue

  1. ARH missense polymorphisms and plasma cholesterol levels
  2. Genetic and immunological analyses of patients with increased serum butyrylcholinesterase activity and its C5 variant form
  3. Polymorphisms in the P-selectin (CD62P) and P-selectin glycoprotein ligand-1 (PSGL-1) genes and coronary heart disease
  4. Odd-numbered long-chain fatty acids in erythrocyte phospholipids as long-term follow-up parameter in propionic acidemia
  5. Simplified method for the diameter sizing of serum low-density lipoprotein using polyacrylamide gradient gel electrophoresis
  6. In vitro inhibition of fibrinolysis by apolipoprotein(a) and lipoprotein(a) is size- and concentration-dependent
  7. Comparison of cardiac troponin T and I in healthy men and in aortic valve replacement
  8. Evaluation of a shorter methionine loading test
  9. Homocysteine, vitamin B12 and folate in vascular dementia and in Alzheimer disease
  10. The clinical impact of screening for gestational diabetes
  11. Comparison between creatinine and pregnanediol adjustments in the retrospective analysis of urinary hormone profiles during the human menstrual cycle
  12. The measurement of complexed prostate-specific antigen has a better performance than total prostate-specific antigen
  13. Effect of prolonged physical exercise on urinary proANP1-30 and proANP31-67
  14. Diagnostic efficiency of different amphetamine screening tests – the search for an optimal cutoff
  15. Evaluation of a new lithium colorimetric assay performed on the Dade Behring Dimension® X-pand™ system
  16. Reference interval of serum insulin concentrations
  17. Significant decimals and rounding
  18. Questionable results – who directs the EQAS organisers?
  19. Wood WG. Questionable results – who directs the EQAS organisers?
  20. Wood WG. Questionable results – who directs the EQAS organisers?
  21. Wood WG. Questionable results – who directs the EQAS organisers?
  22. Wood WG. Questionable results – who directs the EQAS organisers?
  23. Wood WG. Questionable results – who directs the EQAS organisers? A comment from the point of view of the ECAT Foundation
  24. International Swiss MedLab 2004 and 8th Alps Adria Congress / Laboratory Medicine: From Atomic absorption to Zeta-Globin Lucerne, Switzerland, October 5–9, 2004
Downloaded on 23.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2004.200/html
Scroll to top button